Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats

Reproduction

Volumn 127, Issue 4, 2004, Pages 483-489

  Gomez R ^a   Lima, I ^a   Simon C ^a,b   Pellicer, A ^a,b,c  

^a IVI Foundation   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; KETAMINE; MESSENGER RNA; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; SERIC GONADOTROPIN; SODIUM CHLORIDE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; FEMALE; HORMONE ACTION; IMMATURITY; LOW DRUG DOSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PHYSICIAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK REDUCTION; STATISTICAL ANALYSIS; SUPEROVULATION; UTERINE TUBE;

ANIMALIA;

EID: 1942472046     PISSN: 14701626     EISSN: None     Source Type: Journal    
DOI: 10.1530/rep.1.00129     Document Type: Article

References (30)

1. Bomsel-Helmreich O, Huyen LN & Durand-Gasselin I 1989 Effects of varying doses of HCG on the evolution of preovulatory rabbit follicles and oocytes. Human Reproduction 4 636-642.
2. Chandrasekhar Y & Armstrong DT 1988 Human chorionic gonadotropin and luteinizing hormone-releasing hormone reverse the blockade of ovulation in pregnant mare's serum gonadotropin-primed immature rats by the anti-androgenic drug, hydroxyflutamide. Canadian Journal of Physiology and Pharmacology 66 783-787.
3. Chang P, Kenley S, Burns T, Denton G, Currie K, DeVane G & O'Dea L 2001 Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovitrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertility and Sterility 76 67-74.
4. Chomczynski P & Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
5. Christenson LK & Stouffer RL 1997 Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles. Journal of Clinical Endocrinology and Metabolism 82 2135-2142.
6. Dekel N, Ayalon D, Lewysohn O, Nevo N, Kaplan-Kraicer R & Shalgi R 1995 Experimental extension of the time interval between oocyte maturation and ovulation: effect on fertilization and first cleavage. Fertility and Sterility 64 1023-1028.
7. Diedrich K, Ludwig M & Felberbaum RE 2001 The role of gonadotropin-releasing hormone antagonists in in vitro fertilization. Seminars in Reproductive Medicine 19 213-220.
8. Dissen GA, Lara HE, Fahrenbach WH, Costa ME & Ojeda SR 1994 Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression. Endocrinology 134 1146-1154.
9. Galway AB, LaPolt PS, Tsafriri A, Dargan CM, Boine I & Hsueh AJ 1990 Recombinant follicle-stimulating hormone induces ovulation and tissue plasminogen activator expression in hypophysectomized rats. Endocrinology 127 3023-3028.
10. Gomez R, Simon C, Remohi J & Pellicer A 2002 Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology 143 4339-4348.
11. Gomez R, Simon C, Remohi J & Pellicer A 2003 Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biology of Reproduction 68 2164-2171.
12. Hoff JD, Quigley ME & Yen SSC 1983 Hormonal dynamics at midcycle: a reevaluation. Journal of Clinical Endocrinology and Metabolism 57 792-796.
13. Laitinen M, Ristimaki A, Honkasalo M, Narko K, Paavonen K & Ritvos O 1997 Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Endocrinology 138 4748-4756.
14. Lyons CA, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB & Haning RV Jr 1994 Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Human Reproduction 9 792-799.
15. Manau D, Fabregues F, Arroyo V, Jimenez W, Vanrell JA & Balasch J 2002 Hemodynamic changes induced by urinary human chorionic gonadotropin and recombinant luteinizing hormone used for inducing final follicular maturation and luteinization. Fertility and Sterility 78 1261-1267.
16. Meduri G, Charnaux N, Driancourt MA, Combettes L, Granet P, Vannier B et al. 2002 Follicle-stimulating hormone receptors in oocytes? Journal of Clinical Endocrinology and Metabolism 87 2266-2276.
17. Montgomery-Rice VC, Zusmanis K, Malter H & Mitchell-Leef D 1993 Pure FSH alone induces ovulation and subsequent pregnancy in the mouse resulting in fetal development. Life Sciences 53 31-39.
18. Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich K et al. 1995 Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. Journal of Clinical Endocrinology and Metabolism 80 1967-1971.
19. Pellicer A, Palumbo A, De Cherney AH & Naftolin F 1988 Blockage of ovulation by an angiotensin antagonist. Science 240 1660-1661.
20. Pellicer A, Parmer TG, Stoane JM & Behrman HR 1989 Desensibilization to follicle-stimulating hormone in cumulus cells is coincident with hormone induction of oocyte maturation in rat follicle. Molecular and Cellular Endocrinology 64 179-188.
21. Speroff L, Glass RH & Kase NG 1999 Regulation of the menstrual cycle. In Clinical Gynecology, Endocrinology and Infertility, 6th edn, pp 201-246. Baltimore, MD: Williams & Wilkins.
22. The European Recombinant Human Chorionic Gonadotrophin Study Group 2000 Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment - recombinant HCG versus urinary HCG. Human Reproduction 15 446-451.
23. The European Recombinant LH Study Group 2001 Recombinant human luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. Journal of Clinical Endocrinology and Metabolism 86 2607-2618.
24. Trinchard-Lugan I, Khan A, Porchet HC & Munafo A 2002 Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers. Reproductive Biomedicine Online 4 106-115.
25. Ujioka T, Matsuura K, Kawano T & Okamura H 1997 Role of progesterone in capillary permeability in hyperstimulated rats. Human Reproduction 12 1629-1634.
26. Vasseur C, Rodien P & Beau I et al. 2003 A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. New England Journal of Medicine 349 753-759.
27. Wang J, Luo F, Lu JJ, Chen PK, Liu P & Zheng W 2002 VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors. International Journal of Cancer 97 163-167.
28. Yeh J & Adashi EY 1999 The ovarian life cycle. In Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management, 4th edn, pp 153-190. Eds SSC Yen, RB Jaffe & RL Barbieri. Philadelphia, PA: WB Saunders Co.
29. Yen SSC, Llenera G, Little B & Pearson O 1968 Disappearance rate of endogenous luteinizing hormone and chorionic gonadotropin in man. Journal of Clinical Endocrinology and Metabolism 28 1763-1767.
30. Zelinski-Wooten MB, Hutchison JS, Hess DL, Wolf DP & Stouffer RL 1998 A bolus of recombinant human follicle stimulating hormone at midcycle induces periovulatory events following multiple follicular development in macaques. Human Reproduction 13 554-560.